sar425899 sanofi glp-1 glucagon dual agonist Focus on Glucagon-like Peptide- 1 Target: Drugs Approved or Designed to Treat Obesity Multiagonists Currently in Development. |
Description
Pi-Sunyer (92) et al
Worthington, J
A.HeimesaatM
A summary of the key preclinical and clinical findings on GLP-1RAs and DPP-4is in neuropathic pain models is presented in Table 1, highlighting their proposed mechanisms of action and therapeutic outcomes across various studies
Scintigraphy remains the gold-standard technique but is limited by cost, availability, and exposure to ionizing radiation (37)
doi: 10.1126/scitranslmed.aat3392 55 HeimbrgerSMBergmannNCAugustinRGasbjergLSChristensenMBKnopFK
